Savara
SVRA
#6066
Rank
A$1.59 B
Marketcap
A$7.79
Share price
-1.45%
Change (1 day)
91.10%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2026 (TTM): -A$0.2 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.18 Billion a decrease over its 2024 earnings that were of -A$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.2 Billion13.15%
2025 -A$0.18 Billion23.94%
2024 -A$0.14 Billion75.29%
2023 -A$78.49 Million43.38%
2022 -A$54.75 Million-11.31%
2021 -A$61.73 Million-13.3%
2020 -A$71.2 Million-36.53%
2019 -A$0.12 Billion13.76%
2018 -A$98.61 Million105.54%
2017 -A$47.98 Million34.11%
2016 -A$35.78 Million-37.43%
2015 -A$57.17 Million38.81%
2014 -A$41.19 Million33.62%
2013 -A$30.83 Million38.49%
2012 -A$22.26 Million24.59%
2011 -A$17.87 Million-36.5%
2010 -A$28.14 Million-3.14%
2009 -A$29.05 Million-23.28%
2008 -A$37.86 Million8.52%
2007 -A$34.89 Million-34.14%
2006 -A$52.97 Million184.43%
2005 -A$18.63 Million90.75%
2004 -A$9.77 Million190.35%
2003 -A$3.37 Million11.64%
2002 -A$3.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.33 Billion 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$26.06 Million-85.98%๐Ÿ‡บ๐Ÿ‡ธ USA